Immunoglobulin Light Chain Amyloidosis
📧 Sign up to get email alerts when something new happens for Immunoglobulin Light Chain Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion [Phase 1, Phase 2]
A Phase 1/2 clinical trial from AbbVie evaluating intravenous Etentamig (ABBV-383) in adults with AL amyloidosis; the study is currently rec…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
This clinical trial is evaluating an 18F-labeled PET imaging tracer called [18F]FT8 for amyloidosis, including cardiac amyloidosis. The stud…